These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 15225830)
41. Cyclooxygenase-2 inhibitor and interferon-beta synergistically induce apoptosis in human hepatoma cells in vitro and in vivo. Nakamoto N; Higuchi H; Kanamori H; Kurita S; Tada S; Takaishi H; Toda K; Yamada T; Kumagai N; Saito H; Hibi T Int J Oncol; 2006 Sep; 29(3):625-35. PubMed ID: 16865278 [TBL] [Abstract][Full Text] [Related]
42. Granulin-epithelin precursor overexpression promotes growth and invasion of hepatocellular carcinoma. Cheung ST; Wong SY; Leung KL; Chen X; So S; Ng IO; Fan ST Clin Cancer Res; 2004 Nov; 10(22):7629-36. PubMed ID: 15569995 [TBL] [Abstract][Full Text] [Related]
43. Brivanib alaninate, a dual inhibitor of vascular endothelial growth factor receptor and fibroblast growth factor receptor tyrosine kinases, induces growth inhibition in mouse models of human hepatocellular carcinoma. Huynh H; Ngo VC; Fargnoli J; Ayers M; Soo KC; Koong HN; Thng CH; Ong HS; Chung A; Chow P; Pollock P; Byron S; Tran E Clin Cancer Res; 2008 Oct; 14(19):6146-53. PubMed ID: 18829493 [TBL] [Abstract][Full Text] [Related]
44. Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo. Yu J; Qiao L; Zimmermann L; Ebert MP; Zhang H; Lin W; Röcken C; Malfertheiner P; Farrell GC Hepatology; 2006 Jan; 43(1):134-43. PubMed ID: 16374840 [TBL] [Abstract][Full Text] [Related]
46. Human multi-drug resistant hepatocellular carcinoma induced in nude mice by B-ultrasonographically-directed orthotopic implantation: a new experimental model. Ding L; Chen XP; Zhang ZW; Jing K; Zhang WG Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):393-8. PubMed ID: 17690036 [TBL] [Abstract][Full Text] [Related]
47. The effect of megestrol acetate on growth of HepG2 cells in vitro and in vivo. Zhang K; Chow PK Clin Cancer Res; 2004 Aug; 10(15):5226-32. PubMed ID: 15297426 [TBL] [Abstract][Full Text] [Related]
48. Regulation of angiogenesis by Id-1 through hypoxia-inducible factor-1alpha-mediated vascular endothelial growth factor up-regulation in hepatocellular carcinoma. Lee TK; Poon RT; Yuen AP; Ling MT; Wang XH; Wong YC; Guan XY; Man K; Tang ZY; Fan ST Clin Cancer Res; 2006 Dec; 12(23):6910-9. PubMed ID: 17145808 [TBL] [Abstract][Full Text] [Related]
49. Delayed cerebral lipiodol embolism after transcatheter arterial chemoembolization of hepatocellular carcinoma. Wu JJ; Chao M; Zhang GQ; Li B Chin Med J (Engl); 2009 Apr; 122(7):878-80. PubMed ID: 19493407 [No Abstract] [Full Text] [Related]
50. Regression of Novikoff rat hepatocellular carcinoma following locoregional administration of a novel formulation of clofazimine in lipiodol. Pourgholami MH; Lu Y; Wang L; Stephens RW; Morris DL Cancer Lett; 2004 Apr; 207(1):37-47. PubMed ID: 15050732 [TBL] [Abstract][Full Text] [Related]
51. Lipiodol ultra-fluid: an antitumor agent-in vitro study. Durand-Fontanier S; Simon A; Duroux JL; Descottes B; Delage C Anticancer Res; 1999; 19(5B):4357-61. PubMed ID: 10628401 [TBL] [Abstract][Full Text] [Related]
52. Preoperative treatment of hepatocellular carcinoma with intra-arterial injection of 131I-labelled lipiodol (Br J Surg 2003; 90: 1379-1383). Rai R; Rai S Br J Surg; 2004 Mar; 91(3):373; author reply 373. PubMed ID: 14991642 [No Abstract] [Full Text] [Related]
53. [Recent advances in research on SMANCS]. Maeda H Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():1-9. PubMed ID: 9512680 [TBL] [Abstract][Full Text] [Related]
54. Human liver cancer cells and endothelial cells incorporate iodised oil. Bhattacharya S; Dhillon AP; Winslet MC; Davidson BR; Shukla N; Gupta SD; Al-Mufti R; Hobbs KE Br J Cancer; 1996 Apr; 73(7):877-81. PubMed ID: 8611399 [TBL] [Abstract][Full Text] [Related]
55. New insights into the role of vitamin D in hepatocellular carcinoma. Wu DB; Wang ML; Chen EQ; Tang H Expert Rev Gastroenterol Hepatol; 2018 Mar; 12(3):287-294. PubMed ID: 29140126 [TBL] [Abstract][Full Text] [Related]
56. I-131-lipiodol cytotoxicity in hepatoma cells. Chou FI; Lui WY; Chi CW; Chan WK Proc Natl Sci Counc Repub China B; 1994 Oct; 18(4):154-60. PubMed ID: 7701014 [TBL] [Abstract][Full Text] [Related]
57. The tissue-specific distribution of 3H-seocalcitol (EB 1089) and 3H-calcitriol in rats. Kissmeyer AM; Nielsen JL; Binderup L J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):43-7. PubMed ID: 15225745 [TBL] [Abstract][Full Text] [Related]
58. Phase II trial of oral 1,25-dihydroxyvitamin D (calcitriol) in hormone refractory prostate cancer. Osborn JL; Schwartz GG; Smith DC; Bahnson R; Day R; Trump DL Urol Oncol; 1995; 1(5):195-8. PubMed ID: 21224117 [TBL] [Abstract][Full Text] [Related]
59. Current therapies in alleviating liver disorders and cancers with a special focus on the potential of vitamin D. Khan S; Ali A; Khan S; Bakillah A; Damanhouri G; Khan A; Makki A; AlAnsari I; Banu N Nutr Metab (Lond); 2018; 15():13. PubMed ID: 29449867 [TBL] [Abstract][Full Text] [Related]
60. Vitamin D and GI cancers: shedding some light on dark diseases. Hargrove L; Francis T; Francis H Ann Transl Med; 2014 Jan; 2(1):9. PubMed ID: 25332985 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]